Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jay Lobell Insider Profile
11 Followers
Jay Lobell, Director at Fortress Biotech, holds 115.69K shares in Fortress Biotech (Ticker: FBIO), holds 0.00 shares in Pardes Biosciences (Ticker: PRDS), holds 0.00 shares in Keryx Biopharma (Ticker: KERX).
Jay Lobell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Jay Lobell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jay Lobell
Jay Lobell's Trading History
Fortress Biotech
Jan 03, 2024
Director
Uninformative Buy
―
$194.36K
Pardes Biosciences
Aug 31, 2023
―
Uninformative Sell
―
$0.00
Keryx Biopharma
―
―
―
$0.00
Talon Therapeutics Inc
―
―
―
―
List of latest transactions for each holding click on a transaction to see Jay Lobell's performance on stock
You May Also Like
Jay Lobell insider profile FAQ
What is the percentage of profitable transactions made by Jay Lobell?
The percentage of profitable transactions made by Jay Lobell is ―.
What is the average return per transaction made by Jay Lobell?
The average return per transaction made by Jay Lobell is ―.
What stocks does Jay Lobell hold?
Jay Lobell holds: FBIO, PRDS, KERX, TLON stocks.
What was Jay Lobell’s latest transaction?
Jay Lobell latest transaction was an Uninformative Buy of ―.
What was Jay Lobell's most profitable transaction?
Jay Lobell’s most profitable transaction was an Informative Buy of FBIO stock on February 14, 2023. The return on the trade was -81.50%.
What is Jay Lobell's role in Fortress Biotech?
Jay Lobell's role in Fortress Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.